Australian medical technology company Global Kinetics, which makes a smart watch-style device to help treat patients with Parkinson’s disease, has appointed a new chief executive from San Francisco as part of its strategy to help drive the company’s US growth.

The leadership change for the business, which makes a device called the Parkinson’s KinetiGraph (PKG) that looks like a smart watch but actually records specific movement data of Parkinson’s sufferers, comes after it raised $14.8 million last year from a range of investors including Brandon Capital Partners, in order to enter the US market.

Read more on The Australian Financial Review here.